Vivani Medical VANI
NASDAQ VANI
$1.38 -0.03 (-2.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Vivani Medical (VANI) Other Non-Current Liabilities (2021 - 2026)

Vivani Medical (VANI) posted quarterly Other Non-Current Liabilities of $16.5 million for Q1 2026, down 6.44% year-over-year from $17.6 million in Q1 2025, and down 3.33% quarter-over-quarter from $17.1 million in Q4 2025.

Vivani Medical (VANI) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Vivani Medical's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $16.5 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 6.44% year-over-year to $16.5 million; the TTM figure through Mar 2026 stood at $16.5 million (down 6.44% YoY), while the FY2025 annual figure was $17.1 million, down 5.03% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $16.5 million, down from $17.1 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $20.1 million in Q2 2023, with the low at $42000.0 in Q3 2022.
  • The 5-year median for Other Non-Current Liabilities is $17.6 million (2025), against an average of $14.7 million.
  • The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities surged 46754.76% in 2023, then dropped 7.58% in 2025.
  • Vivani Medical's Other Non-Current Liabilities stood at $1.7 million in 2022, then surged by 1053.01% to $19.3 million in 2023, then declined by 6.98% to $18.0 million in 2024, then decreased by 5.03% to $17.1 million in 2025, then declined by 3.33% to $16.5 million in 2026.
  • Business Quant data shows VANI's Other Non-Current Liabilities at $16.5 million in Q1 2026, $17.1 million in Q4 2025, and $16.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Vivani Medical 120.18 Mn 100.29 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 16.01 Mn
Mar 31, 2026 16.49 Mn
Dec 31, 2025 17.06 Mn
Sep 30, 2025 16.91 Mn
Jun 30, 2025 17.28 Mn
Mar 31, 2025 17.63 Mn
Dec 31, 2024 17.97 Mn
Sep 30, 2024 18.29 Mn
Jun 30, 2024 18.62 Mn
Mar 31, 2024 18.94 Mn
Dec 31, 2023 19.31 Mn
Sep 30, 2023 19.68 Mn
Jun 30, 2023 20.13 Mn
Mar 31, 2023 349,000.00
Dec 31, 2022 1.68 Mn
Sep 30, 2022 42,000.00
Dec 31, 2021 902,000.00